Sartorius’ $100m Puerto Rico expansion enables greater supply for US industry

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/dennisvdw)
(Image: Getty/dennisvdw)

Related tags: Sartorius, Puerto rico, Supply and demand, downstream systems, processing, equipment, Single-use technology, Single-use systems, Manufacturing

Sartorius’ investment in Puerto Rico site doubles production capacity of manufacturing equipment for the biopharmaceutical industry.

The $100m (€89.2m) investment at the Yauco, Puerto Rico, facility doubled the production capacity of membrane filters and single-use bags for biopharmaceutical manufacture, most of which are supplied to the US.

Joachim Kreuzburg, CEO and executive board chairman of Sartorius, said in a statement, “Operationally and strategically, this expansion is an important investment for us. The considerably higher production capacities created as a result now give us leeway to deliver an even wider product array directly from the region to our American customers and to implement our ambitious growth plans in the Americas.”

After three years of construction, the factory site is 2m-square-feet and is designed to enable additional growth in the long-term, as Sartorius can double its manufacturing capabilities once more if needed.

Sartorius opened its facility in Yauco and has been manufacturing filter membranes there since 1982, adding the production of sterile single-use bags in 2012. The facility currently employees more than 500 people.

According to this was the first time Sartorius added production capacity for manufacturing filter membranes outside of its headquarters in Göttingen, Germany.

The company currently has 60 manufacturing and sales sites across the globe, employing 8,500 people. Sartorius reported global revenue of $1.68bn in FY18 results.

In March 2019, Sartorius and Novasep​ collaborated to introduce new membrane technology and single -use solutions into the company’s applications. In doing so, the partnership saw Sartorius supply products for both upstream and downstream processing equipment.

Related news

Show more

Related products

show more

How Viral Safety Testing Will Evolve

How Viral Safety Testing Will Evolve

Viral Safety for mAb: Prevent, Detect, Remove | 20-May-2020 | Event Programme

The pressure to shorten delivery times and reduce costs for biologics are driving an evolution in the biomanufacturing space. Many of the methods used...

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Small-Scale Cell Culture Perfusion Process

Small-Scale Cell Culture Perfusion Process

Eppendorf for Bioprocess – Solutions that grow with you | 29-Mar-2019 | Application Note

Perfusion cell culture processes promise advantages for industrial bioprocessing, like saving space, increasing volumetric productivity, achieving more...

Related suppliers

Follow us


View more